Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
|Videos|September 24, 2013
Uncovering Cost-Saving Opportunities for Specialty Infusions
Michael Einodshofer of Walgreens identifies the various charges that can be included in the total cost of an infusion in a hospital setting.
Advertisement
Michael Einodshofer of Walgreens identifies the various charges that can be included in the total cost of an infusion in a hospital setting. He also discusses the "creative" billing methodologies that some hospitals use to squeeze more revenue out of these procedures.
For more videos from industry experts, please visit our
Advertisement
Related to this article
Pharmacists can reduce COVID-19 vaccine hesitancy through honest, nonjudgmental communication and by using every patient touchpoint as an opportunity to offer vaccination.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
From insurance delays to injection concerns, pharmacists can help patients navigate the first month and avoid preventable treatment interruptions.
Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association discusses pharmacists’ role in diabetes and CKD care from ASN Kidney Week 2026
Pharmacy Times featured experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 ‘Is Not Done With Us’: Pharmacist Urges Continued Vaccination Ahead of Seasonal Peaks
2
Tarlatamab and Next-Generation Targeted Agents Headline ESMO 2026 Lung Cancer Data
3
PCSK9 Inhibition Lowers LDL-C in Patients With Kidney Disease
4
Ribociclib Survival Data Anchor a Sobering ESMO 2026 for Breast Cancer
5